What is the recommended intravenous (IV) dosage of cefuroxime for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefuroxime IV Dosage for Pediatric Patients

For pediatric patients above 3 months of age, administer cefuroxime IV at 50-100 mg/kg/day divided into equally divided doses every 6-8 hours for most infections, with higher dosing of 100 mg/kg/day (not exceeding maximum adult dosage) reserved for more severe or serious infections. 1

Standard Dosing by Infection Severity

Mild to Moderate Infections

  • 50-100 mg/kg/day IV divided into equally divided doses every 6-8 hours 1
  • This dosing range has demonstrated efficacy in clinical trials for pneumonia, with mean serum concentrations of 29.1 mcg/mL achieved 30 minutes after a 25 mg/kg IV dose 2
  • Studies using 75 mg/kg/day divided every 8 hours showed 100% clinical efficacy in pediatric pneumonia and soft-tissue infections 2, 3

Severe or Serious Infections

  • 100 mg/kg/day IV (not to exceed maximum adult dosage) in equally divided doses every 6-8 hours 1
  • For bone and joint infections specifically: 150 mg/kg/day IV (not to exceed maximum adult dosage) in equally divided doses every 8 hours 1

Bacterial Meningitis

  • 200-240 mg/kg/day IV in divided doses every 6-8 hours 1
  • This higher dosing achieves adequate CSF penetration, with documented spinal fluid levels of 9.0 mcg/mL at 30 minutes and 3.8 mcg/mL at 2 hours after a 52.2 mg/kg dose 4

Dosing Adjustments for Renal Insufficiency

  • In pediatric patients with renal insufficiency, modify the frequency of dosing consistent with adult recommendations 1
  • For creatinine clearance 10-20 mL/min: reduce to every 12 hours 1
  • For creatinine clearance <10 mL/min: reduce to every 24 hours 1

Administration Guidelines

IV Preparation and Administration

  • Constitute each 750-mg vial with 8.3 mL Sterile Water for Injection (concentration: 90 mg/mL) 1
  • Constitute each 1.5-gram vial with 16 mL Sterile Water for Injection (concentration: 90 mg/mL) 1
  • Direct IV injection: slowly inject over 3-5 minutes 1
  • Intermittent IV infusion: administer through Y-type set, temporarily discontinuing other solutions at the same site 1

Duration of Therapy

  • Continue for minimum 48-72 hours after patient becomes asymptomatic or bacterial eradication is documented 1
  • Minimum 10 days recommended for Streptococcus pyogenes infections to prevent rheumatic fever or glomerulonephritis 1
  • Oral antibiotics may be administered following completion of parenteral therapy when appropriate 1, 2

Clinical Efficacy Data

  • Clinical cure/improvement rates of 100% demonstrated in pediatric skin and soft-tissue infections 5
  • Bacteriologic eradication achieved in 93.2-100% of cases 5
  • Effective against Haemophilus influenzae (including beta-lactamase-positive strains), Streptococcus pneumoniae, and Staphylococcus aureus 2, 3

Important Caveats

  • Do not confuse with oral cefuroxime axetil dosing (20-50 mg/kg/day), which is significantly lower than IV dosing (50-200 mg/kg/day) 6
  • All infants <6 months with serious infections should be hospitalized regardless of antibiotic choice 6
  • Eosinophilia may occur in approximately 10% of patients but is generally benign 2
  • Transient granulocytopenia (<1,500/mm³) has been reported but causality unclear 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.